Semin intervent Radiol 2015; 32(04): 374-378
DOI: 10.1055/s-0035-1564792
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVac

George Behrens
1  Department of Interventional Radiology, VIR Chicago at Hinsdale Adventist Hospital, Hinsdale, Illinois
,
Haraldur Bjarnason
2  Division of Interventional Radiology, Department of Radiology, Mayo Clinic, Rochester, Minnesota
› Author Affiliations
Further Information

Publication History

Publication Date:
10 November 2015 (online)

Abstract

Central venous thrombosis is a complex problem, particularly in cases where the thrombus burden is large. Several interventional techniques and devices have been developed over the past 15 to 20 years to manage this entity, but the vast majority of them still need the concomitant use of thrombolytics to achieve an optimal result. AngioVac (AngioDynamics, Latham, NY) is the first aspiration thrombectomy device capable to remove a larger burden of undesired intravascular material such as thrombus, tumor, and foreign bodies without the need of lytics. This review focuses on the AngioVac device in the management of iliocaval thrombosis and pulmonary embolism.